The Global Deep Brain Stimulation (DBS) Systems Market is predicted to reach a market valuation of USD 2,122.8 million by 2027, expanding at a CAGR of 8.1% according to a recent report by Emergen Research. A large proportion of the geriatric population suffers from involuntary movements of the body, caused due to Parkinson’s disease (PD), dystonia, and multiple sclerosis. In the U.S., nearly 60,000 people are diagnosed with PD annually, and approximately 10 million people live with PD across the globe. High prevalence of neurological and movement disorders in the elderly population, coupled with their escalating number, is driving the demand for deep brain stimulation systems, thereby driving the market demand. Additionally, increasing incidences of depression, essential tremors, and OCD are further adding traction to market growth.
Minimally-invasive surgeries play a pivotal role in the treatment of neurological symptoms like tremors, loss of movement control, and rigidity, among other symptoms leading to PD and dystonia. DBS systems incorporated in the brain ensures minimal damage is caused to the surrounding healthy brain tissues while treating the neurological symptoms. Technologically upgraded implanted DBS systems can be recharged wireless without needing further surgeries. However, side effects associated with surgical intervention and drugs and high costs of the procedures and treatment are expected to impede the market growth.
Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample-form/45
Top Companies in Deep Brain Stimulation Systems Market are:
Medtronic, Abbott, NeuroPace, Cyberonics, Fisher Wallace, Aleva Neurotherapeutics, and Boston Scientific Corporation, among others.
Deep Brain Stimulation Systems Market Drivers During Forecast Period:
By Product Outlook Segment:
Dual Channel DBS systems sub-segment accounted for a substantial share of the industry, occupying a 57.8% share. The growth can be accredited to the increasing use of advanced technology and enhanced safety attributes, such as painless management and wireless recharge capability, to reduce tremors linked with Parkinson’s disease.
By Regional Outlook Segment:
North America led the industry with a sizeable market share in the DBS systems market attributable to the rising incidences of depression disorders, fast-paced product approvals from FDA, and favorable reimbursement policies.
Key Highlights from the Report:
- Rising occurrences of involuntary body movements, predominantly in the geriatric population across the globe, has boosted the growth of the Parkinson’s disease application sub-segment. The sub-segment is anticipated to dominate market growth, occupying a share of approximately 39.7% of the global market.
- By the end of 2020, nearly 930,000 people are expected to be diagnosed with PD in the United States. This, in turn, bolstering the demand for deep brain stimulation systems equipped with advanced features that minimize occurrences of tremors associated with PD.
- Escalating patient pool suffering from PD, dystonia, epilepsy, and depression, among other neurological conditions in countries, such as India and China, are boosting the market growth in the APAC region. The APAC region reported the highest CAGR of 9% in 2019 and is expected to exhibit lucrative growth in the coming period.
ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.emergenresearch.com/select-license/45
For the purpose of this report, Emergen Research has segmented the Global Deep Brain Stimulation (DBS) Systems Market on the basis of product, application, end-user, and region:
Product Outlook (Revenue, USD Million; 2017–2027)
- Single Channel
- Dual-Channel
Application Outlook (Revenue, USD Million; 2017–2027)
- Parkinson’s disease
- Fluid Replacement
- Obsessive-Compulsive Disorder (OCD)
- Pain Management
- Essential Tremor
- Epilepsy
- Dystonia
- Depression
- Others
End-Use Outlook (Revenue, USD Million; 2017–2027)
- Ambulatory Care Centre
- Hospitals
- Neurology Centers
- Others
To identify the key trends in the industry and read full summary click on the link: https://www.emergenresearch.com/industry-report/deep-brain-stimulation-system-market
Regional Outlook (Revenue, USD Million; 2017–2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- Rest of MEA
Insights into our Other Published Healthcare Reports:
Pharmacovigilance Market Size Worth USD 12.48 Billion by 2027 | CAGR of 12.5%
Radiation Dose Management Market to Reach USD 505.3 Million By 2027 | CAGR of 12.6%
Cell Culture Market Size Worth USD 45.12 Billion By 2027 | CAGR of 10.3%
Gene Editing Market Size Worth USD 15.79 Billion By 2027 | CAGR of 17.2%
Joint Reconstruction Devices Market Size Worth USD 36.81 Billion By 2027 | CAGR of 6.3%
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
